TORONTO - Crystallex International Corporation (AMEX, TSX: KRY) announced today that the over-allotment option granted to the underwriters in connection with its previously closed Cdn$100 million equity financing was fully exercised and has closed for gross proceeds of Cdn$15 million.  A syndicate of underwriters purchased 3,750,000 common shares of Crystallex at a price of Cdn$4.00 per share.

Crystallex plans to use the net proceeds from the financing to fund development costs at the Las Cristinas Project in Venezuela.

This press release is not an offer to sell or the solicitation of an offer to buy the common shares, nor shall there be any sale of the common shares in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction.  The common shares being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such common shares may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.

The Toronto Stock Exchange has not reviewed this release and does not accept responsibility for the adequacy or accuracy of this news release.